According to Elanco's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.29086. At the end of 2023 the company had a P/S ratio of 1.14.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.14 | -12.75% |
2022 | 1.31 | -53.45% |
2021 | 2.82 | -36.28% |
2020 | 4.42 | 23.61% |
2019 | 3.58 | -4.83% |
2018 | 3.76 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | 1.41 | 8.87% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | 71.2 | 5,414.11% | ๐บ๐ธ USA |